Practices NOT currently participating in Phase 1b rollout
Practices who are not currently participating in Phase 1b COVID-19 vaccine rollout may be asked by their patients to provide proof so they can access the vaccine from another practice. The following records may be relied upon as evidence:
My Health Record – Shared Health Summary
a written referral from GP
a printout of an individual’s medical history, or chronic disease care plan
The easiest way for the practice to do this (and to meet one of the requirements for ePIP at the same time) is to upload a Shared Health Summary to the patients My Health Record. This can then be accessed by the vaccine clinic, as well as be seen by the patient (via MyGov) if they need to provide any details of their illness or eligibility.
How do I upload a Shared Health Summary? Click below for a simple demonstration:
Practices should confirm that proof of eligibility meets one of the accepted types for the first dose and make a simple record of proof. This is not required for the second dose as long as the first dose is registered in Australian Immunisation Register (AIR).
If you are providing a COVID-19 vaccine to a patient who does not regularly attend your practice, you can access the information within the My Health Record to check for any medical history, allergies or medication history.
You should also check a patient’s vaccination history on AIR to confirm appropriate interval between a doses of COVID-19 vaccine and/or of seasonal influenza vaccine are observed.
Immunisation providers are expected to login and view the new information. A summary of the updates can be found in the announcement forum. All changes within the modules are identified by ‘NEW’ in red.”
“IMPORTANT – ATAGI have released new recommendations for AstraZeneca:
The COVID-19 vaccine by Pfizer (COMIRNATY) is preferred over the COVID-19 Vaccine AstraZeneca in adults aged under 50 years, who have not already had a first dose of the COVID-19 AstraZeneca vaccine.
COVID-19 Vaccine AstraZeneca can be used in adults aged under 50 years where the benefits are likely to outweigh the risks for that individual and the person has made an informed decision based on an understanding of the risks and benefits (ATAGI, 2021d).”
COVID-19 vaccine uptake and acceptance
2021 NCIRS COVID-19 vaccine webinar series focusing on practical advice for improving COVID-19 vaccine uptake and acceptance.
• hear an update on COVID-19 vaccine uptake in Australia • hear the latest research on Australian attitudes towards COVID-19 vaccines • learn evidence-based strategies for increasing COVID-19 vaccine acceptance among your patients, colleagues, family and friends.
COVID-19 vaccine updates for GPs
Join the latest COVID-19 vaccine live stream update for GPs.
The panel will provide latest key updates and answer participants’ questions live about the COVID-19 vaccine rollout.
Target audience: GPs and all health professionals
Details: Thursday 22 April, 11:30am-12:30pm (AEDT)
Maroubra Medicare Urgent Care Clinic (UCC) is now open The Maroubra Medicare Urgent Care Clinic (UCC) is now open, seven days a week, from 8.00am to 8.00pm. It was officially launched by member for Kingsford Smith, the hon Matt Thistlethwaite MP (pictured at the launch with CESPHN CEO Nathalie Hansen…
Media Release: Central and Eastern Sydney PHN releases Healthy Ageing Strategy to empower older people In response to the increasing longevity and rapid growth of the older population the Central and Eastern Sydney Primary Health Network (CESPHN) is proud to release its new Healthy Ageing Strategy 2023-2028. This comprehensive strategy…
Immunisation Weekly Update: Are your vaccines ready for summer? In the summer season, storms are more likely to occur, which can lead to power outages. Refer to the Cold Chain Toolkit to ensure all vaccination storage requirements are in place should an outage occur. Disposal of Zostavax® Zostavax® vaccine will…
Immunisation Weekly Update: COVID-19 XBB.1.5 vaccine onboarding The Australian Government has accepted the latest advice from ATAGI on the use of the new COVID-19 XBB 1.5 vaccine as part of the National COVID-19 Vaccine Program. All sites currently participating in the COVID-19 Vaccination Program will be onboarded for the three…
Immunisation Weekly Update: Increase in COVID-19 infection cases ATAGI notes a recent increase in COVID-19 cases since November 2023 across Australia and encourages all eligible people who have not yet had their recommended 2023 COVID-19 vaccine dose/s to receive them as soon as possible. A first 2023 dose is recommended…
Immunisation Weekly Update: Vaccination coverage in RACF Australian Immunisation Register (AIR) data suggests that only 36% of people aged 70+ living in the central and eastern Sydney PHN region are immunised against Pneumococcal diseases. Immunisation providers are reminded to check AIR immunisation history statements of patients going into Residential Aged…
Immunisation Weekly Update: Introduction of Shingrix® to the NIP From 1 November 2023, the shingles vaccine Shingrix® will replace Zostavax® on the National Immunisation Program (NIP) schedule for the prevention of shingles and post-herpetic neuralgia. It will be available for eligible people most at risk of complications from shingles. A…
NSW urged to prepare for heat wave Severe heatwave conditions are forecast in NSW in the coming days. Please read the NSW Health media release about taking steps to prevent heat-related illness. For further information about staying safe in a heatwave, visit Beat the heat and stay well during hot…